cDNAs encoding mouse Cx50 and rat Cx46 in the pSP64TII
vector
13 were provided by Thomas W. White and
Daniel A. Goodenough (Harvard University, Boston, MA). To
generate Cx50D47A, two primers corresponding to adjacent regions in the
E1 domain of Cx50 were synthesized. The sense primer,
5′-CTGAGCAATCTGATTTTGTATGCAACACC-3′, corresponding to nucleotides from
406 to 434, contained nucleotides encoding amino acid 47 to 56 of Cx50,
with nucleotide 406 changed from A to C, resulting in the conversion of
aspartic acid 47 to alanine. The antisense primer,
5′-CGCCCCACACAAACTCCGCT-3′, corresponding to nucleotides from 405 to
386, corresponds to amino acids 40 to 47 of Cx50. Cx50 in the SP64T
vector was amplified using a commercial kit (LA PCR; Takara
Shuzo, Ostsu, Japan) according to the manufacturer’s protocol.
The polymerase chain reaction (PCR) conditions were as follows: 1
minute at 94°C; 25 cycles at 98°C for 20 seconds and 68°C for 10
minutes; and 1 cycle at 72°C for 10 minutes. The PCR-amplified
product was digested with the restriction enzyme,
DpnI, to
select against the parental, nonreplicated DNA.
14 Subsequently, the PCR-amplified product was purified with a PCR
purification kit (QIAquick; Qiagen, Chatsworth, CA), polished with a
PCR polishing kit (Stratagene, La Jolla, CA), and ligated to itself to
generate Cx50D47A SP64T. The mutant construct was sequenced to ensure
that PCR amplification did not introduce any new mutations (DNA
Sequencing Facility, Iowa State University, Ames, IA). The recombinant
plasmid DNA was linearized with the restriction enzyme
,
SalI. cRNAs were in vitro transcribed with SP6 polymerase
(mMessage mMachine kit; Ambion, Austin, TX) following the
manufacturer’s protocol. The transcripts were purified on a G-50
Sephadex column (Boehringer Mannheim, Indianapolis, IN) to remove
unincorporated rNTPs, precipitated with isopropanol, and resuspended in
diethyl pyrocarbonate–treated water. The cRNA was quantitated by
measuring the absorbance at 260 nm and stored as 3-μl aliquots at–
80°C.